NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Aug. 07, 2024 |
May 01, 2023 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Aug. 31, 2023 |
|
| Accounting Policies [Abstract] | |||||||||
| Reverse stock split | one post-split share per sixty thousand pre-split shares (1:60,000) | one-for-one thousand (1:1,000) | |||||||
| Cumulative exchange gain (loss) | $ 1,339,000 | $ (416,000) | |||||||
| Cumulative exchange gain (loss) | (1,339,000) | 416,000 | |||||||
| Cash and cash equivalents | 0 | $ 0 | $ 0 | $ 0 | |||||
| Refundable advance deposit | $ 120,958 | ||||||||
| Allowance for recoverability of refundable advance deposit | 120,958 | ||||||||
| Prepaid expenses, current | 9,680,347 | 9,680,347 | |||||||
| Prepaid expenses noncurrent | 12,695,648 | 12,695,648 | |||||||
| Deferred offering cost | 92,117 | 92,117 | 27,117 | ||||||
| GST tax receivable | $ 3,633 | $ 3,633 | $ 2,950 | $ 2,867 | |||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||
| Research and development costs | $ 54,097 | $ 65,448 | $ 170,199 | $ 195,712 | $ 248,102 | $ 247,919 | |||
| Beneficial ownership conversion description | Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance. | Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance | |||||||
| Beneficial ownership percentage | 4.99% | 4.99% | |||||||
| Foreign currency transaction, gain | $ 90,000 | 648,000 | |||||||
| Research and development tax credit | $ 129,132 | $ 129,841 | |||||||
| X | ||||||||||
- Definition Allowance for recoverability of refundable advance deposit. No definition available.
|
| X | ||||||||||
- Definition GST tax receivable. No definition available.
|
| X | ||||||||||
- Definition Refundable advance deposit. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of conversion terms for debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion. No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cumulative translation gain (loss), before tax, from translating foreign currency financial statements into the reporting currency. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|